[Guay DR. An update on the role of nitrofurans in the management of urinary tract infections. Drugs 2001;61:353-64.10.2165/00003495-200161030-00004]Search in Google Scholar
[Abboud G, Kaplowitz N. Drug-induced liver injury. Drug Saf 2007;30:277-94.10.2165/00002018-200730040-00001]Search in Google Scholar
[Boelsterli UA, Ho HK, Zhou S, Leow KJ. Bioactivation and hepatotoxicitiy of nitroaromatic drugs. Curr Drug Metab 2006;7:715-27.10.2174/138920006778520606]Search in Google Scholar
[Holmberg L, Boman G, Bottiger LE, Eriksson B, Spross R, Wessling A. Adverse reactions to nitrofurantoin. Analysis of 921 reports. Am J Med 1980;69:733-8.10.1016/0002-9343(80)90443-X]Search in Google Scholar
[Vrhovac B. Farmakoterapijski priručnik [Manual of Pharmacotherapy, in Croatian], 5th edition. Zagreb: Medicinska naklada; 2007.]Search in Google Scholar
[Beigel R, Perets R, Mouallem M. Acute kidney injury, hepatitis, and CPK elevation associated with nitrofurantoin therapy. Am J Med Sci 2009;337:132-3.10.1097/MAJ.0b013e31816c43a4]Search in Google Scholar
[Bruel H, Guillemant V, Saladin-Thiron C, Chabrolle JP, Lahary A, Poinsot J. Anéie héolytique chez un nouveauné aprè prise maternelle de nitrofurantoïne en fin de grossesse [Hemolytic anemia in a newborn after maternal treatment with nitrofurantoin at the end of pregnancy, in French]. Arch Pediatr 2000;7:745-7.10.1016/S0929-693X(00)80155-4]Search in Google Scholar
[Heber MF, Roberts JP. Endstage liver disease associated with nitrofurantoin requiring liver transplantation. Ann Pharmacother 1993;27:1193-4.10.1177/1060028093027010078251685]Search in Google Scholar
[Millson LC, Angus P, Richards M, Jones RM, Ireton J. Hepatitis due to nitrofurantoin. Med J Aust 1992;156:347-9.10.5694/j.1326-5377.1992.tb139795.x1588868]Search in Google Scholar
[Volbeda F, Jonker AM, Vecht J, Groeneveld PH. Levercirrose door chronisch gebruik van nitrofurantoïne [Liver cirrhosis due to chronic use of nitrofurantoin, in Dutch]. Ned Tijdschr Geneeskd 2004;148:235-8.]Search in Google Scholar
[Dam-Larsen S, Kromann-Andersen H. Nitrofurantoin-levertoksicitet. Tilfaelde indberettet til Bivirkningsnaevnet 1968-1998. [Hepatic toxicity of nitrofurantoin. Cases reported to the Center for Monitoring Adverse Drug Reactions 1968-1998, in Danish]. Ugeskr Laeger 1999;161:6650-2.]Search in Google Scholar
[Amit G, Cohen P, Ackerman Z. Nitrofurantoin-induced chronic active hepatitis. Isr Med Assoc J 2002;4:184-6.]Search in Google Scholar
[Paterna JC, Boess F, Stäubli A, Boelsterli UA. Antioxidant and cytoprotective properties of D-tagatose in cultured murine hepatocytes. Toxicol Appl Pharmacol 1998;148:117-25.10.1006/taap.1997.83159465271]Search in Google Scholar
[Kelly BD, Heneghan MA, Bennani F, Connolly CE, O'Gorman TA. Nitrofurantoin-induced hepatotoxicity mediated by CD8+ T cells. Am J Gastroenterol 1998;93:819-21.]Search in Google Scholar
[Paiva LA, Wright PJ, Koff RS. Long-term hepatic memory for hypersensitivity to nitrofurantoin. Am J Gastroenterol 1992;87:891-3.]Search in Google Scholar